ArticleClinical & translational immunology2021

C-reactive protein flare-response predicts long-term efficacy to first-line anti-PD-1-based combination therapy in metastatic renal cell carcinoma.

Niklas Klümper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.